$3.5 Million Available in Cooperative Agreements for Existing Drugs, Biologics Pre-Clinical Studies
Grants
Copyright © Targeted News Service, 2016
Copyright © Targeted News Service, 2016
2016-08-27
by ELIZABETH TELAN
WASHINGTON, Aug. 27 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award up to 10 cooperative agreements for supporting pre-clinical studies to repurpose existing drugs or biologics.
This funding opportunity uses the phase innovation awards mechanism.
The estimated total program funding available was cited as $3.5 million.
This funding opportunity is open to state, county, city, township . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Aug. 27 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award up to 10 cooperative agreements for supporting pre-clinical studies to repurpose existing drugs or biologics.
This funding opportunity uses the phase innovation awards mechanism.
The estimated total program funding available was cited as $3.5 million.
This funding opportunity is open to state, county, city, township . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com